German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

Atara Biotherapeutics' cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according to the EMA's human medicines ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

Key Takeaways Psoriasis makes skin cells grow too fast, forming thick, scaly patchesGenes plus triggers like stress, ...

Global Biopharma Leader Streamlines Pharmacovigilance with 90% Data Accuracy and Enhanced Efficiency BOSTON, July 8, 2025 /PRNewswire/ -- ArisGlobal, an AI-first technology company at the ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that may cause pain and disability. It may be managed with medication and lifestyle changes. While PsA isn’t life threatening ...

After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here’s what to know if you have to make a switch. [1] ...